Preprint finds 33-fold rise in documented BPC-157 use across 15 million records
nference researchers identified 1,039 patients with recorded use between 2020 and 2026, most of it buried in clinical notes rather than prescription data.
PR
By Priya Raman · Science Reporter
Oct 4 06:40 ETSource: Healthline
The wire
- 01A September 2026 preprint analyzing more than 15 million medical records identified 1,039 documented BPC-157 users and a roughly 33-fold increase in new users from 2020 to 2026.
- 02About 33% of patients reported using BPC-157 for pain relief versus 4% for performance enhancement; 27% of the cohort reported improvement, with pain relief documented in 183 patients and tissue healing in 38.
- 03The analysis is a preprint and relies on clinical narrative, not prescriptions; it follows the July FDA advisory panel vote recommending BPC-157 and other peptides be eligible for compounding.
From the source
Read at healthline.comWolverine’ Peptide: Do 'Regeneration' Benefits Outweigh Risks?
Wellness seekers are increasingly turning to BPC-157, the wildly popular “Wolverine” peptide for injury recovery and pain relief, despite scant human evidence.
